AstraZeneca India gets CDSCO nod to introduce Durvalumab for advanced liver cancer
IBNS-CMEDIA: AstraZeneca Pharma India Ltd. (AZPIL) has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted approval for an additional indication of Durvalumab. The therapy can now be …
Read More